BFC Planning’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.32M Buy
12,664
+2,972
+31% +$784K 0.13% 161
2026
Q2
$2.14M Sell
9,692
-284
-3% -$78.6K 0.09% 233
2026
Q1
$2.95M Buy
9,976
+613
+7% +$182K 0.13% 160
2025
Q4
$2.56M Buy
9,363
+8,472
+951% +$2.3M 0.11% 174
2025
Q3
$241K Buy
891
+59
+7% +$16.1K 0.02% 613
2025
Q2
$229K Buy
832
+3
+0.4% +$816 0.02% 586
2025
Q1
$220K Buy
829
+8
+1% +$1.97K 0.02% 573
2024
Q4
$191K Buy
821
+56
+7% +$12.9K 0.02% 636
2024
Q3
$169K Buy
+765
New +$158K 0.01% 670

Other funds holding CME

BFC Planning's CME Position: Q3 2026 in Review

BFC Planning increased its CME Group (CME) stake by 31% in Q3 2026, buying an estimated $784K and bringing the position to 12,664 shares worth $3.32M. The position accounts for 0.13% of the portfolio, ranked #161.

BFC Planning first reported a position in CME in Q3 2024 and has held it in 9 quarters since. 1,503 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • BFC Planning held 12,664 shares of CME Group worth $3.32M as of Q3 2026.
  • BFC Planning bought 2,972 CME Group shares in Q3 2026, an estimated $784K.
  • CME Group made up 0.13% of BFC Planning's portfolio in Q3 2026, its #161 holding.
  • BFC Planning first reported a position in CME Group in Q3 2024 and has held it in 9 quarters since.
  • 1,503 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.